+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pediatric Clinical Trials Global Market Report 2024

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • The Business Research Company
  • ID: 5850444
The pediatric clinical trials market has grown strongly in recent years. It will grow from $16.31 billion in 2023 to $17.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth observed in the historical period can be ascribed to several pivotal factors. Regulatory incentives played a significant role in incentivizing advancements in pediatric medicine by encouraging research and development tailored specifically to children's medical needs. Additionally, addressing unmet medical needs in pediatric care fueled innovations and advancements, stimulating growth within this domain. Progress in pediatric medicine, driven by global public health initiatives and ethical imperatives, further contributed to this growth trajectory. Notably, the success and expansion of pediatric vaccination programs also played a crucial role in enhancing healthcare for children, thereby contributing to the overall growth observed in this period.

The pediatric clinical trials market is expected to see strong growth in the next few years. It will grow to $22.52 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to integration of real-world evidence, pediatric biomarker discovery, expanded access programs, pediatric infectious disease research, pediatric cardiology advancements. Major trends in the forecast period include patient-centric trial design, adoption of adaptive trial designs, digital health technologies, global collaboration and consortia, pediatric oncology advancements.

The rise in pediatric cancer cases is expected to drive the pediatric clinical trials market forward. Pediatric cancers, though rare, exhibit unique growth patterns distinct from adult tumors, necessitating specialized research and treatments. Pediatric clinical trials play a pivotal role in advancing prognosis and treatment methods. According to the American Cancer Society's estimates in January 2023, approximately 9,910 children in the US under 15 will be diagnosed with cancer, with about 1,040 expected deaths in 2023. Consequently, increased healthcare spending fuels the growth of the pediatric clinical trials market.

The burgeoning demand for outsourcing services is set to propel the pediatric clinical trials market's expansion. As preclinical research grows in complexity, pharmaceutical and biotech companies increasingly seek specialized skills beyond their in-house capabilities. Outsourcing services aid in crafting safe, ethical, and scientifically robust pediatric clinical trial protocols. A survey by BioPlan Associates Inc. in April 2023 revealed that around 84.6% of biomanufacturers outsource analytical testing, while 74.5% seek toxicity testing outsourcing, highlighting the surging reliance on outsourcing in pediatric clinical trials, driving market growth.

Product innovation stands out as a pivotal trend reshaping the pediatric clinical trial market. Companies within this sector are investing in innovative products to maintain their market standing. An instance is The Leukemia & Lymphoma Society's launch of the Pediatric Acute Leukemia (PedAL) Master Clinical Trial in June 2022. This groundbreaking trial is tailored to pediatric acute leukemia, leveraging individual tumor biology to match children with the most promising treatments, emphasizing innovation in pediatric cancer research.

Major players in pediatric clinical trials prioritize collaborations and partnerships to deliver dependable services. Strategic partnerships, characterized by structured affiliations between commercial entities, are pivotal in fostering reliability in service provision. Strados Labs' collaboration with Ann & Robert H. Lurie Children's Hospital in September 2023 exemplifies this approach. Their clinical trial involves the RESP Biosensor, a wearable device employing acoustic sensors to monitor lung sounds for asthma symptoms. The trial aims to assess the RESP Biosensor's effectiveness in accurately detecting and monitoring asthma exacerbations in children, showcasing partnerships' role in advancing pediatric healthcare technology.

In December 2021, Thermo Fisher Scientific Inc., a prominent US-based manufacturer specializing in medical devices, analytical instruments, reagents, consumables software, and services, successfully acquired PPD, Inc., for a substantial sum of $17.4 billion. This strategic acquisition significantly bolsters and diversifies Thermo Fisher's portfolio, offering an extensive array of top-tier clinical trial development services. These services span the entire spectrum from scientific discovery to evaluating efficacy, safety, and healthcare outcomes, encompassing clinical trial logistics management and drug product development and manufacturing. PPD, Inc., the acquired entity, operates within the pediatric clinical trials market, serving as a US-based clinical research services provider catering to the biopharma and biotech industries. This strategic move aligns with Thermo Fisher's broader objectives of enhancing its capabilities and expanding its offerings within the clinical trial domain.

Major companies operating in the pediatric clinical trials market report are Medpac Inc., Pharmaceutical Product Development Inc., ICON plc, Syneos Health Inc., QPS Holdings LLC, Pfizer Inc., IQVIA Inc., Premier Research, Labcorp - Laboratory Corporation of America Holdings, The Emmes Company LLC, Synteract Inc., Charles River Laboratories International Inc., Covance Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, BioNTech SE, Moderna Inc., Parexel International Corporation, PRA Health Sciences, Wuxi AppTec, Merck & Co. Inc., AstraZeneca plc, Sanofi S.A., Johnson & Johnson, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Oracle Health sciences.

North America was the largest region in the pediatric clinical trials market in 2023. The regions covered in the pediatric clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

These trials typically encompass several distinct phases Phase I, Phase II, Phase III, and Phase IV. Phase I trials primarily concentrate on establishing the safety profile and determining the appropriate dosage range of new medications, typically involving 20-100 healthy volunteers. Diverse study designs, such as treatment and observational studies, are employed across various therapeutic areas. These encompass infectious diseases, oncology, autoimmune or inflammatory diseases, respiratory disorders, mental health disorders, among other medical domains, enabling comprehensive exploration and assessment of treatments for pediatric patients.

The pediatric clinical trials market research report provides pediatric clinical trials market statistics, including pediatric clinical trials industry global market size, regional shares, competitors with a pediatric clinical trials market share, detailed pediatric clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric clinical trials industry. This pediatric clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pediatric clinical trials market includes revenues earned by entities through clinical research services, consulting, outsourcing services, and medical communications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Pediatric Clinical Trials Market Characteristics3. Pediatric Clinical Trials Market Trends and Strategies
4. Pediatric Clinical Trials Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Pediatric Clinical Trials Market Size and Growth
5.1. Global Pediatric Clinical Trials Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Pediatric Clinical Trials Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Pediatric Clinical Trials Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Pediatric Clinical Trials Market Segmentation
6.1. Global Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
6.2. Global Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Treatment Studies
  • Observational Studies
6.3. Global Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infectious Diseases
  • Oncology
  • Autoimmune Or Inflammatory Diseases
  • Respiratory Disorders
  • Mental Health Disorders
  • Other Therapeutic Areas
7. Pediatric Clinical Trials Market Regional and Country Analysis
7.1. Global Pediatric Clinical Trials Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Pediatric Clinical Trials Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Pediatric Clinical Trials Market
8.1. Asia-Pacific Pediatric Clinical Trials Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Pediatric Clinical Trials Market
9.1. China Pediatric Clinical Trials Market Overview
9.2. China Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Pediatric Clinical Trials Market
10.1. India Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Pediatric Clinical Trials Market
11.1. Japan Pediatric Clinical Trials Market Overview
11.2. Japan Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Pediatric Clinical Trials Market
12.1. Australia Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Pediatric Clinical Trials Market
13.1. Indonesia Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Pediatric Clinical Trials Market
14.1. South Korea Pediatric Clinical Trials Market Overview
14.2. South Korea Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Pediatric Clinical Trials Market
15.1. Western Europe Pediatric Clinical Trials Market Overview
15.2. Western Europe Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Pediatric Clinical Trials Market
16.1. UK Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Pediatric Clinical Trials Market
17.1. Germany Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Pediatric Clinical Trials Market
18.1. France Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Pediatric Clinical Trials Market
19.1. Italy Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Pediatric Clinical Trials Market
20.1. Spain Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Pediatric Clinical Trials Market
21.1. Eastern Europe Pediatric Clinical Trials Market Overview
21.2. Eastern Europe Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Pediatric Clinical Trials Market
22.1. Russia Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Pediatric Clinical Trials Market
23.1. North America Pediatric Clinical Trials Market Overview
23.2. North America Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Pediatric Clinical Trials Market
24.1. USA Pediatric Clinical Trials Market Overview
24.2. USA Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Pediatric Clinical Trials Market
25.1. Canada Pediatric Clinical Trials Market Overview
25.2. Canada Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Pediatric Clinical Trials Market
26.1. South America Pediatric Clinical Trials Market Overview
26.2. South America Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Pediatric Clinical Trials Market
27.1. Brazil Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Pediatric Clinical Trials Market
28.1. Middle East Pediatric Clinical Trials Market Overview
28.2. Middle East Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Pediatric Clinical Trials Market
29.1. Africa Pediatric Clinical Trials Market Overview
29.2. Africa Pediatric Clinical Trials Market, Segmentation by Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Pediatric Clinical Trials Market, Segmentation by Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Pediatric Clinical Trials Market, Segmentation by Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Pediatric Clinical Trials Market Competitive Landscape and Company Profiles
30.1. Pediatric Clinical Trials Market Competitive Landscape
30.2. Pediatric Clinical Trials Market Company Profiles
30.2.1. Medpac Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Pharmaceutical Product Development Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. ICON plc
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Syneos Health Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. QPS Holdings LLC
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Pediatric Clinical Trials Market Competitive Benchmarking32. Global Pediatric Clinical Trials Market Competitive Dashboard33. Key Mergers and Acquisitions in the Pediatric Clinical Trials Market
34. Pediatric Clinical Trials Market Future Outlook and Potential Analysis
34.1 Pediatric Clinical Trials Market in 2028 - Countries Offering Most New Opportunities
34.2 Pediatric Clinical Trials Market in 2028 - Segments Offering Most New Opportunities
34.3 Pediatric Clinical Trials Market in 2028 - Growth Strategies
34.3.1 Market Trend-based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic and Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Analyst
35.6. Copyright and Disclaimer

Executive Summary

This report provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pediatric clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for pediatric clinical trials? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:
1) By Phase: Phase I; Phase II; Phase III; Phase IV
2) By Study Design: Treatment Studies; Observational Studies
3) By Therapeutic Areas: Infectious Diseases; Oncology; Autoimmune Or Inflammatory Diseases; Respiratory Disorders; Mental Health Disorders; Other Therapeutic Areas

Key Companies Mentioned: Medpac Inc.; Pharmaceutical Product Development Inc.; ICON plc; Syneos Health Inc.; QPS Holdings LLC

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned

  • Medpac Inc.
  • Pharmaceutical Product Development Inc.
  • ICON plc
  • Syneos Health Inc.
  • QPS Holdings LLC
  • Pfizer Inc.
  • IQVIA Inc.
  • Premier Research
  • Labcorp - Laboratory Corporation of America Holdings
  • The Emmes Company LLC
  • Synteract Inc.
  • Charles River Laboratories International Inc.
  • Covance Inc.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • BioNTech SE
  • Moderna Inc.
  • Parexel International Corporation
  • PRA Health Sciences
  • Wuxi AppTec
  • Merck & Co. Inc.
  • AstraZeneca plc
  • Sanofi S.A.
  • Johnson & Johnson
  • Eli Lilly and Company
  • Takeda Pharmaceutical Company Limited
  • C.H. Boehringer Sohn AG & Co. KG
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Oracle Health sciences

Methodology

Loading
LOADING...